Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding.
about
CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestionPathogenesis of human immunodeficiency virus infectionGlycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 bindingEffects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoproteinThe N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4.Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoproteinCD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment.Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120.The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site.Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacityMapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4.Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine.Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1.Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor bindingEffects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity.Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef.The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism.Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region
P2860
Q24559959-BBF36B00-8021-4EEC-B7FE-1B30A7FCB292Q24634681-92494AA5-2635-4CF7-8B8A-03BDBFE79D23Q24644617-C339C3CA-1822-4B6D-8859-992BBF73943CQ28646850-E9E9C50A-1A73-4237-9DB7-EC599441D227Q33579510-7FBB0AF3-06C5-427C-B1A6-83C28A5C7DE9Q33936268-B86D2DCF-7439-42EF-A34E-887BC61F047EQ33937274-B98EBCD3-B431-4550-8BC6-8FB039C3A3B2Q35876191-60E8BBA5-8EDC-43AA-8BBE-4B0D978D9DB1Q36365085-93A5889A-97AD-46F9-B7E2-C690FB82E79EQ36630580-416F8D11-7C78-429A-904F-F67CF7795979Q36649075-400D5DFD-47E6-41B5-9C1D-C0BB2194416AQ36669879-30D76F90-28D2-4B44-BC8B-1F310FFA48F2Q36687749-B041CD42-C2F3-45B4-97CC-74DF281B3B00Q36689153-A2D86B79-49ED-4BD4-A90C-51A017466922Q36690417-F108E9AB-DE31-416B-8690-9B98F9151F6EQ36697574-A9E96246-6DB2-47FA-A54D-58132E12C547Q36698665-B0432C74-83EB-4589-B946-B6EF126EDEFEQ36699051-AAEB6DBF-306F-4187-9A5E-204A5205210CQ36795606-839247F9-3D3A-4144-8DFB-73ECC490B844Q36797873-51EF5959-CC26-4127-A8CE-BF6DD0B33E5FQ37374127-8A68450C-E662-42FC-A36B-E4E12D1A18C2Q40045300-BDC1D861-4FD3-4A95-889F-43ECB89FB1BAQ40049070-4B9FD853-1818-4D22-AEBD-4829303283B9Q40106668-B694B8AE-9D5C-48D0-8CB4-78896877BF81Q40308489-A4BFE756-4BFF-4299-8F1A-9F5367102516Q41516510-CF84B817-4BCC-45C8-9BE7-B9731B604E62
P2860
Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Effects of mutations in hyperc ...... us type 1 on receptor binding.
@en
type
label
Effects of mutations in hyperc ...... us type 1 on receptor binding.
@en
prefLabel
Effects of mutations in hyperc ...... us type 1 on receptor binding.
@en
P2093
P2860
P1433
P1476
Effects of mutations in hyperc ...... rus type 1 on receptor binding
@en
P2093
Cordonnier A
P2860
P304
P407
P577
1989-10-01T00:00:00Z